| http://dbpedia.org/ontology/abstract
|
PRC200-SS is an experimental drug of the t … PRC200-SS is an experimental drug of the triple reuptake inhibitor class that was investigated by the Mayo Clinic. Preclinical toxicology studies of PRC200-SS in cynomolgus monkeys showed dose proportional kidney toxicity, precluding any further drug development., precluding any further drug development.
|
| http://dbpedia.org/ontology/casNumber
|
492434-58-9
|
| http://dbpedia.org/ontology/pubchem
|
20631904
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/PRC200_structure.png?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
23928336
|
| http://dbpedia.org/ontology/wikiPageLength
|
3052
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1120772415
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Amines +
, http://dbpedia.org/resource/Category:Serotonin%E2%80%93norepinephrine%E2%80%93dopamine_reuptake_inhibitors +
, http://dbpedia.org/resource/Mayo_Clinic +
, http://dbpedia.org/resource/Triple_reuptake_inhibitor +
, http://dbpedia.org/resource/Crab-eating_macaque +
, http://dbpedia.org/resource/Category:Secondary_alcohols +
, http://dbpedia.org/resource/Preclinical +
, http://dbpedia.org/resource/Category:Abandoned_drugs +
, http://dbpedia.org/resource/Drug_development +
, http://dbpedia.org/resource/Category:2-Naphthyl_compounds +
|
| http://dbpedia.org/property/c
|
20
|
| http://dbpedia.org/property/casNumber
|
492434
|
| http://dbpedia.org/property/chemspiderid
|
19318181
|
| http://dbpedia.org/property/h
|
21
|
| http://dbpedia.org/property/iupacName
|
-3
|
| http://dbpedia.org/property/n
|
1
|
| http://dbpedia.org/property/o
|
1
|
| http://dbpedia.org/property/pubchem
|
20631904
|
| http://dbpedia.org/property/smiles
|
O[C@H][C@H]c2cc3ccccc3cc2
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
RSZGIFQDUIROGN-WOJBJXKFSA-N
|
| http://dbpedia.org/property/verifiedfields
|
changed
|
| http://dbpedia.org/property/verifiedrevid
|
451223794
|
| http://dbpedia.org/property/watchedfields
|
changed
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Antidepressants +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Stdinchicite +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Monoamine_reuptake_inhibitors +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Cascite +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Abandoned_drugs +
, http://dbpedia.org/resource/Category:Serotonin%E2%80%93norepinephrine%E2%80%93dopamine_reuptake_inhibitors +
, http://dbpedia.org/resource/Category:2-Naphthyl_compounds +
, http://dbpedia.org/resource/Category:Amines +
, http://dbpedia.org/resource/Category:Secondary_alcohols +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/PRC200-SS?oldid=1120772415&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/PRC200_structure.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/PRC200-SS +
|
| owl:sameAs |
https://global.dbpedia.org/id/4ssBH +
, http://www.wikidata.org/entity/Q7120261 +
, http://sr.dbpedia.org/resource/PRC200 +
, http://dbpedia.org/resource/PRC200-SS +
, http://sh.dbpedia.org/resource/PRC200 +
|
| rdf:type |
http://dbpedia.org/ontology/Drug +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/ChemicalSubstance +
|
| rdfs:comment |
PRC200-SS is an experimental drug of the t … PRC200-SS is an experimental drug of the triple reuptake inhibitor class that was investigated by the Mayo Clinic. Preclinical toxicology studies of PRC200-SS in cynomolgus monkeys showed dose proportional kidney toxicity, precluding any further drug development., precluding any further drug development.
|
| rdfs:label |
PRC200-SS
|
